Inhibition of growth of primary and metastatic Lewis lung carcinoma cells by the phosphodiesterase inhibitor isobutylmethylxanthine

Cancer Res. 1980 Jun;40(6):1950-4.
No abstract available

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology*
  • 1-Methyl-3-isobutylxanthine / therapeutic use
  • 1-Methyl-3-isobutylxanthine / toxicity
  • Animals
  • Cell Division / drug effects
  • Female
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / pathology
  • Male
  • Mice
  • Neoplasm Metastasis
  • Neoplasms, Experimental / drug therapy
  • Neoplasms, Experimental / pathology*
  • Theophylline / analogs & derivatives*

Substances

  • Theophylline
  • 1-Methyl-3-isobutylxanthine